Cassava Sciences | L'Utile Operativo

Operating Profit Cambiamento Data
Abbott USD 1.39B 403M 2024-03
Amgen USD 991M 280M 2024-03
Biogen USD 570M 211.1M 2024-03
Cassava Sciences USD -27879000 898K 2023-09
Eisai JPY 6.11B 710M 2023-12
Eli Lilly USD 2.74B 347.8M 2024-03
Geron USD -56134000 1.84M 2024-03
J&J USD 6.27B 1.45B 2024-03
Merck USD 5.76B 7.69B 2024-03
Pfizer USD 4.2B 10.75B 2024-03
Roche Holding CHF 9.76B 3.84B 2023-06



Cassava Sciences L'Utile Operativo - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jun 2024.